Results 151 to 160 of about 2,874 (176)

Host control of latent Epstein-Barr virus infection

open access: yes
Schmidt A   +11 more
europepmc   +1 more source

Discovery of the First Selective Nanomolar Inhibitors of ERAP2 by Kinetic Target‐Guided Synthesis

open access: yesAngewandte Chemie - International Edition, 2022
AbstractEndoplasmic reticulum aminopeptidase 2 (ERAP2) is a key enzyme involved in the trimming of antigenic peptides presented by Major Histocompatibility Complex class I. It is a target of growing interest for the treatment of autoimmune diseases and in cancer immunotherapy.
Virgyl Camberlein   +2 more
exaly   +4 more sources

ERAP1 and ERAP2 Enzymes: A Protective Shield for RAS against COVID-19? [PDF]

open access: yesInternational Journal of Molecular Sciences, 2021
Patients with coronavirus disease 2019 (COVID-19) have a wide variety of clinical outcomes ranging from asymptomatic to severe respiratory syndrome that can progress to life-threatening lung lesions. The identification of prognostic factors can help to improve the risk stratification of patients by promptly defining for each the most effective therapy ...
Silvia D'Amico   +2 more
exaly   +6 more sources

A Short ERAP2 That Binds IRAP Is Expressed in Macrophages Independently of Gene Variation [PDF]

open access: yesInternational Journal of Molecular Sciences, 2022
The M1 zinc metalloproteases ERAP1, ERAP2, and IRAP play a role in HLA-I antigen presentation by refining the peptidome either in the ER (ERAP1 and ERAP2) or in the endosomes (IRAP). They have also been entrusted with other, although less defined, functions such as the regulation of the angiotensin system and blood pressure.
Silvana Caristi   +2 more
exaly   +3 more sources

Home - About - Disclaimer - Privacy